Concepedia

Publication | Closed Access

Effects of estradiol–drospirenone on ocular and nasal functions in postmenopausal women

30

Citations

36

References

2011

Year

Abstract

Oral daily treatment with drospirenone 2 mg + estradiol 1 mg reduces the risks for ocular diseases and nasal obstruction in postmenopausal women.

References

YearCitations

Page 1